bioMérieux S.A. (BMXMF)
USD 103.09
(0.0%)
USD 103.09
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.88 Billion EUR | -6.07% |
| 2022 | 2 Billion EUR | 2.29% |
| 2021 | 1.96 Billion EUR | 11.98% |
| 2020 | 1.75 Billion EUR | 19.57% |
| 2019 | 1.46 Billion EUR | 12.62% |
| 2018 | 1.3 Billion EUR | 7.47% |
| 2017 | 1.21 Billion EUR | 10.09% |
| 2016 | 1.1 Billion EUR | 11.27% |
| 2015 | 989.2 Million EUR | 17.13% |
| 2014 | 844.5 Million EUR | 2.41% |
| 2013 | 824.6 Million EUR | 1.28% |
| 2012 | 814.2 Million EUR | 6.98% |
| 2011 | 761.1 Million EUR | 5.4% |
| 2010 | 722.1 Million EUR | 9.48% |
| 2009 | 659.6 Million EUR | 11.23% |
| 2008 | 593 Million EUR | 4.81% |
| 2007 | 565.8 Million EUR | 4.41% |
| 2006 | 541.9 Million EUR | 4.13% |
| 2005 | 520.4 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.06 Billion EUR | 9.44% |
| 2023 Q4 | 971.1 Million EUR | 6.06% |
| 2023 FY | 1.88 Billion EUR | -6.07% |
| 2023 Q2 | 915.6 Million EUR | -10.15% |
| 2022 FY | 2 Billion EUR | 2.29% |
| 2022 Q2 | 913.1 Million EUR | -12.22% |
| 2022 Q4 | 1.01 Billion EUR | 11.6% |
| 2021 Q4 | 1.04 Billion EUR | 14.72% |
| 2021 FY | 1.96 Billion EUR | 11.98% |
| 2021 Q2 | 906.7 Million EUR | -2.38% |
| 2020 Q4 | 928.8 Million EUR | 15.04% |
| 2020 FY | 1.75 Billion EUR | 19.57% |
| 2020 Q2 | 807.4 Million EUR | 8.0% |
| 2019 Q2 | 701.1 Million EUR | 4.96% |
| 2019 Q4 | 747.6 Million EUR | 6.63% |
| 2019 FY | 1.46 Billion EUR | 12.62% |
| 2018 Q2 | 634.3 Million EUR | 4.53% |
| 2018 FY | 1.3 Billion EUR | 7.47% |
| 2018 Q4 | 668 Million EUR | 5.31% |
| 2017 Q4 | 606.8 Million EUR | 0.3% |
| 2017 FY | 1.21 Billion EUR | 10.09% |
| 2017 Q2 | 605 Million EUR | 3.97% |
| 2016 Q4 | 581.9 Million EUR | 12.16% |
| 2016 FY | 1.1 Billion EUR | 11.27% |
| 2016 Q2 | 518.8 Million EUR | 0.62% |
| 2015 FY | 989.2 Million EUR | 17.13% |
| 2015 Q4 | 515.6 Million EUR | 8.87% |
| 2015 Q2 | 473.6 Million EUR | 3.05% |
| 2014 Q2 | 384.9 Million EUR | -10.09% |
| 2014 FY | 844.5 Million EUR | 2.41% |
| 2014 Q4 | 459.6 Million EUR | 19.41% |
| 2013 Q4 | 428.1 Million EUR | 7.97% |
| 2013 FY | 824.6 Million EUR | 1.28% |
| 2013 Q2 | 396.5 Million EUR | 0.0% |
| 2012 Q4 | - EUR | 0.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 FY | 814.2 Million EUR | 6.98% |
| 2011 Q2 | - EUR | 0.0% |
| 2011 Q4 | - EUR | 0.0% |
| 2011 FY | 761.1 Million EUR | 5.4% |
| 2010 Q2 | - EUR | 0.0% |
| 2010 FY | 722.1 Million EUR | 9.48% |
| 2010 Q4 | - EUR | 0.0% |
| 2009 Q4 | - EUR | 0.0% |
| 2009 FY | 659.6 Million EUR | 11.23% |
| 2008 FY | 593 Million EUR | 4.81% |
| 2007 FY | 565.8 Million EUR | 4.41% |
| 2006 FY | 541.9 Million EUR | 4.13% |
| 2005 FY | 520.4 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 977664.767% |
| Arrayit Corporation | 2.57 Million USD | -73168.253% |
| Atlantic International Corp. | -154.23 Thousand USD | 1223371.133% |
| Biocept, Inc. | -2.58 Million USD | 73171.263% |
| Bioqual, Inc. | 7.42 Million USD | -25295.965% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 276 Thousand USD | -683486.957% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 72.007% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | -105062.183% |
| iMD Companies, Inc. | -23.63 Thousand USD | 7982077.408% |
| IDenta Corp. | 662.97 Thousand USD | -284480.867% |
| Interpace Biosciences, Inc. | 23.04 Million USD | -8087.736% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | -2432123.382% |
| InVitro International | 635.98 Thousand USD | -296557.94% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | -28647.524% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | -172566.571% |
| NovelStem International Corp. | 12 Thousand USD | -15722400.0% |
| Optigenex Inc. | -102.96 Thousand USD | 1832452.427% |
| PharmChem, Inc. | 3.9 Million USD | -48222.703% |
| Proteome Sciences plc | 2.09 Million USD | -89887.222% |
| Response Genetics, Inc | 3.94 Million USD | -47761.492% |
| Rennova Health, Inc. | 6.26 Million USD | -29999.305% |
| RushNet, Inc. | 1.1 Million USD | -170701.592% |
| ScreenPro Security Inc. | 856.57 Thousand USD | -220161.18% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 467397.59% |
| Todos Medical Ltd. | 4.31 Million USD | -43674.942% |